Goldman Sachs Group Inc Astrazeneca PLC Put Options Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $2.34 Million - $2.83 Million	35,000 Added 100.0%	70,000 $5.46 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $18.4 Million - $20.9 Million	-301,000 Reduced 89.58%	35,000 $2.37 Million
Q1 2023 May 14, 2024	BUY	$63.15 - $71.6 $6.19 Million - $7.02 Million	98,000 Added 41.18%	336,000 $23.3 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $6.19 Million - $7.02 Million	98,000 Added 41.18%	336,000 $23.3 Million
Q2 2022 May 14, 2024	SELL	$59.26 - $71.14 $5.81 Million - $6.97 Million	-98,000 Reduced 29.17%	238,000 $15.7 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $5.91 Million - $7.12 Million	106,136 Added 80.49%	238,000 $15.8 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $7.33 Million - $8.02 Million	131,864 New	131,864 $7.92 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.